SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-035245
Filing Date
2023-07-19
Accepted
2023-07-19 17:27:26
Documents
12
Period of Report
2023-07-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20056035_8k.htm   iXBRL 8-K 45409
  Complete submission text file 0001140361-23-035245.txt   187340

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycn-20230719.xsd EX-101.SCH 3868
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20230719_lab.xml EX-101.LAB 23290
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20230719_pre.xml EX-101.PRE 16554
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc20056035_8k_htm.xml XML 4223
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 231097623
SIC: 2834 Pharmaceutical Preparations